OCLR and Scheimpflug-Placido topographer effective for corneal measurements

Article

Using an optical low-coherence reflectometry (OLCR) biometer and Scheimpflug-Placido topographer are both as effective for measuring corneal parameters

Using an optical low-coherence reflectometry (OLCR) biometer and Scheimpflug-Placido topographer are both as effective for measuring corneal parameters, claims a study in the Journal of Cataract and Refractive Surgery.

Dr Wuhe Chen et al., Eye Hospital of Wenzhou Medical College, Wenzhou, China, evaluated 40 subjects. One randomly healthy eye of each participant was measured three times with both devices.

The parameters measured included central corneal thickness (CCT), anterior chamber depth (ACD) from the corneal epithelium and from the endothelium, mean keratometry (K) and white-to-white (WTW) corneal diameter.

Within-subject standard deviation was used to calculate the repeatability of the scans. Agreement between the two devices was evaluated using the Bland-Altman limits of agreement (LoA) method. A mean of three scans were performed in order to assess LoA.

Repeatability of the Scheimpflug-Placido topographer and OLCR biometer was 3.10 μm and 3.32 μm for CCT. For WTW corneal diameter was 0.04 mm and 0.05 mm and for mean K it was 0.17 D and 0.10 D for mean K for the the Scheimpflug-Placido topographer and OLCR biometer, respectively.

According to the Bland-Altman LoA analysis, all parameters were within clinically sufficient limits. Both devices presented good repeatability for all parameters and can be used interchangeably between parameters.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.